Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.74% | 306.72 | 0.0% | $5256.57m | |
| BNTX | BioNTech SE | 3.17% | 344.06 | 0.0% | $1596.83m | |
| NVAX | Novavax, Inc. | -0.92% | 160.48 | 78.2% | $831.00m | |
| AMGN | Amgen, Inc. | 0.63% | 202.44 | 1.4% | $596.39m | |
| GILD | Gilead Sciences, Inc. | -0.16% | 69.56 | 1.0% | $505.86m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.18% | 635.16 | 2.7% | $472.48m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.31% | 203.81 | 1.9% | $464.56m | |
| LGVN | Longeveron Inc. | 11.78% | 20.12 | 0.0% | $429.77m | |
| ILMN | Illumina, Inc. | -2.85% | 347.28 | 3.3% | $324.28m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -4.21% | 4.10 | 0.7% | $286.61m | |
| BIIB | Biogen, Inc. | -2.01% | 223.92 | 1.8% | $276.52m | |
| INCY | Incyte Corp. | -1.28% | 65.78 | 2.4% | $150.25m | |
| SGEN | Seagen Inc. | -5.00% | 150.74 | 5.8% | $149.09m | |
| EXAS | EXACT Sciences Corp. | -4.94% | 76.59 | 18.0% | $140.15m | |
| OCGN | Ocugen, Inc. | -8.72% | 5.76 | 0.0% | $139.18m |
Company Profile
Esperion Therapeutics, Inc. is a pharmaceutical company. It engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.